MSH2 c.676G>T ;(p.E226*)

Variant ID: 2-47639583-G-T

NM_000251.2(MSH2):c.676G>T;(p.E226*)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations.

Journal For Immunotherapy Of Cancer
Castro, Michael P MP; Goldstein, Neal N
Publication Date: 2015

Variant appearance in text: MSH2: E226*
PubMed Link: 26674132
Variant Present in the following documents:
  • Main text
  • 40425_2015_Article_104.pdf
View BVdb publication page